(Q47312067)

13 January 2018

title

Increase in visfatin after weight loss induced by gastroplastic surgery (English)

1 reference

13 January 2018

author name string

Katarzyna Krzyzanowska

1

1 reference

13 January 2018

Friedrich Mittermayer

2

1 reference

13 January 2018

Walter Krugluger

3

1 reference

13 January 2018

Hans Peter Kopp

4

1 reference

13 January 2018

Guntram Schernthaner

5

1 reference

13 January 2018

publication date

1 November 2006

1 reference

13 January 2018

published in

Obesity

1 reference

13 January 2018

volume

14

1 reference

13 January 2018

issue

11

1 reference

13 January 2018

page(s)

1886-1889

1 reference

13 January 2018

Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.219

Impact of Weight Loss on Inflammatory Proteins and Their Association With the Insulin Resistance Syndrome in Morbidly Obese Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.219

RETRACTED: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.219

Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.219

Plasma visfatin concentrations and fat depot-specific mRNA expression in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.219

Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.219

Interleukin-6 is a negative regulator of visfatin gene expression in 3T3-L1 adipocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.219

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.219

Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.219

Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.219

Visfatin is an adipokine, but it is not regulated by thiazolidinediones

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.219

31 March 2020

Identifiers

DOI

10.1038/OBY.2006.219

1 reference

13 January 2018

PubMed ID

17135602

1 reference

13 January 2018